SamuelssonBGoldyneMGranströmEHambergMHammarströmSMalmstenC. Prostaglandins and thromboxanes. Annu Rev Biochem1978;47:997–1029.
2.
HammarströmS. Leukotrienes. Annu Rev Biochem1983;52:355–77.
3.
SamuelssonB. Leucotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science1983;220:568–75.
4.
HonaSLLevineL. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci USA May1976;73(5):1730–4.
5.
HirataFSchiffmannEVenkatasubramanianKSalomonDAxelrodJ. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Aci USA May1980;77(5):2533–6.
6.
HambergMSamuelssonB. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci USA Mar1973;70(3):899–903.
7.
HamberoMSvenssonJSamuelssonB. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA Aug1975;72(8): 2994–8.
8.
MoncadaSGryglewskiRBuntingSVaneJR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature1976;263:663–5.
9.
MalmstenCHambergMSvenssonJSamuelssonB. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci USA Apr1975;72(4):1446–50.
10.
VaneJR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biol Jun 231971;231(25):232–5.
11.
JohanssonCKollbergBNordemarRSamuelsonKBergströmS. Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology Mar1980;78(3):479–83.
12.
RådmarkOMalmstenCSamuelssonBClarkDAGotoGMarfatACoreyEJ. Leukotriene A: stereochemistry and enzymatic conversion to leukotriene B. Biochem Biophys Res Commun Feb 121980;92(3):954–61.
13.
BorgeatPSamuelssonB. Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. Proc Natl Acad Sci USA Jul1979;76 (7):3213–17.
14.
MalmstenCLPalmbladJUdnA-MRådmarkOEngstedtLSamuelssonB. Leukotriene B4: A highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes. Acta Physiol Scand1980;110:449–51.
15.
FeinmarkSJLindgrenJAClaessonHEMalmstenCSamuelssonB. Stimulation of human leukocyte degranulation by leukotriene B4 and its omega-oxidized metabolites. FEBS Lett Dec 211981;136(1):141–4.
16.
DahlënSEBjörkJHedqvistPArforsKEHammarströmSLindgrenJASamuelssonB. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA Jun1981;78(6):3887–91.
17.
HanssonGLindgrenJADahlënSEHedqvistPSamuelssonB. Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett Jul 201981;130(1):107–12.
18.
RaeSADavidsonEMSmithMJ. Leukotriene B4, an inflammatory mediator in gout. Lancet Nov 201982;2(8308):1122–4.
19.
KlicksteinLBShapleighCGoetzlEJ. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest Nov1980;66(5):1166–70.
20.
SamuelssonBHammarströmSMurphyRCBorgeatP. Leukotrienes and slow reacting substance of anaphylaxis (SRS-A). Allergy Jul1980;35(5):375–81.
21.
AustenKF. Homeostasis of effector systems which can also be recruited for immunologic reactions. J Immunol Sep1978;121(3):793–805.
22.
ConroyMCOrangeRPLichtensteinLM. Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes and the calcium ionophore A23187. J Immunol Jun1976;116(6):1677–81.
23.
HedqvistPDahlenSEGustafssonLHammarströmSSamuelssonB. Biological profile of leukotrienes C4 and D4. Acta Physiol Scand Nov1980;110(3):331–3.
